Medical Guidelines and Performance Measures: The Need to Keep Them Free of Industry Influence

Por Eichacker, Peter Q., Natanson, Charles
Publicado em 2008

The Surviving Sepsis Campaign's Revised Sepsis Bundles

Por Barochia, Amisha V., Cui, Xizhong, Eichacker, Peter Q.
Publicado em 2013

Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy

Por Sherer, Kevin, Li, Yan, Cui, Xizhong, Eichacker, Peter Q.
Publicado em 2007

Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis(*)

Por Barochia, Amisha V., Cui, Xizhong, Natanson, Charles, Eichacker, Peter Q.
Publicado em 2010

Eritoran tetrasodium (E5564) Treatment for Sepsis: Review of Preclinical and Clinical Studies

Por Barochia, Amisha, Solomon, Steven, Cui, Xizhong, Natanson, Charles, Eichacker, Peter Q
Publicado em 2011

B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin components

Por Remy, Kenneth E, Qiu, Ping, Li, Yan, Cui, Xizhong, Eichacker, Peter Q
Publicado em 2013

An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis

Por Ohanjanian, Lernik, Remy, Kenneth E, Li, Yan, Cui, Xizhong, Eichacker, Peter Q
Publicado no Expert Opin Investig Drugs (2015)

Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies

Por Altaweel, Laith, Sweeney, Daniel, Cui, Xizhong, Barochia, Amisha, Natanson, Charles, Eichacker, Peter Q
Publicado em 2009

Anthrax Infection

Por Sweeney, Daniel A., Hicks, Caitlin W., Cui, Xizhong, Li, Yan, Eichacker, Peter Q.
Publicado em 2011

Can we predict the effects of NF-κB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate

Por Li, Xuemei, Su, Junwu, Cui, Xizhong, Li, Yan, Barochia, Amisha, Eichacker, Peter Q
Publicado em 2009

An overview of anthrax infection including the recently identified form of disease in injection drug users

Por Hicks, Caitlin W., Sweeney, Daniel A., Cui, Xizhong, Li, Yan, Eichacker, Peter Q.
Publicado em 2012

The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death

Por Qiu, Ping, Cui, Xizhong, Barochia, Amisha, Li, Yan, Natanson, Charles, Eichacker, Peter Q
Publicado em 2011

Anti-Tumor Necrosis Factor Therapy is Associated with Improved Survival in Clinical Sepsis Trials: A Meta-analysis

Por Qiu, Ping, Cui, Xizhong, Sun, Junfeng, Welsh, Judith, Natanson, Charles, Eichacker, Peter Q.
Publicado em 2013

Practice Misalignments in Randomized Controlled Trials: Identification, Impact and Potential Solutions

Por Deans, Katherine J., Minneci, Peter C., Danner, Robert L., Eichacker, Peter Q., Natanson, Charles
Publicado em 2010

B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model

Por Li, Yan, Cui, Xizhong, Solomon, Steven B., Remy, Kenneth, Fitz, Yvonne, Eichacker, Peter Q.
Publicado em 2013

The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock

Por Hicks, Caitlin W., Cui, Xizhong, Sweeney, Daniel A., Li, Yan, Barochia, Amisha, Eichacker, Peter Q.
Publicado em 2011

Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?

Por Barochia, Amisha V., Li, Yan, Cui, Xizhong, Sweeney, Daniel A., Natanson, Charles, Eichacker, Peter Q.
Publicado em 2009

Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysis

Por Pepper, Dominique J., Sun, Junfeng, Welsh, Judith, Cui, Xizhong, Suffredini, Anthony F., Eichacker, Peter Q.
Publicado no Crit Care (2016)

Neuronal nitric oxide synthase deficiency decreases survival in bacterial peritonitis and sepsis

Por Cui, Xizhong, Besch, Virginia, Khaibullina, Alfia, Hergen, Adrienne, Quezado, Martha, Eichacker, Peter, Quezado, Zenaide M. N.
Publicado em 2007

A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results

Por Xu, Wanying, Ohanjandian, Lernik, Sun, Junfeng, Cui, Xizhong, Suffredini, Dante, Li, Yan, Welsh, Judith, Eichacker, Peter Q.
Publicado no PLoS One (2017)